Facilitated By

San Antonio Medical Foundation

Research Project Qualification Form

2936 Results Page 3 of 294

Investigating alterations in gustatory neuron innervation and function over the course of chemotherapy treatment

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Wood, Ryan
Macpherson, Lindsey
Funded by
NIH Natl Inst of Deafness/Communication

Basic Research

Collaborative Project
Active Project
Regenerative Medicine
Neuroscience
Cancer
Basic Research

Investigating changes in myelin lipid composition during relapsing-remitting neuroinflammation

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Forsthuber, Thomas
Bach, Stephan
Funded by
NIH Natl Inst of Neuro Disorder/Stroke

Basic Research

Collaborative Project
Active Project
Neuroscience
Basic Research

Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Zhao, John
Funded by
Univ of TX HSC at San Antonio 745

Applied Research

Collaborative Project
Active Project
Cancer
Basic Research
Drug Discovery

Transcriptional Misregulation by Aberrant Chromatin Organization in Malignancy

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Soshnev, Alexey
Funded by
Cancer Prevention and Res Inst of TX 527

Basic Research

Collaborative Project
Active Project
Cancer
Basic Research
Disease Modeling
Genetics

Interagency Agreement for GRA Support of PKC-epsilon Program

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
McHardy, Stanton
Funded by
Univ of TX at Austin 721

Basic Research

Collaborative Project
Active Project
Neuroscience
Cancer
Basic Research
Drug Discovery

Human cortical organoids as a cellular readout for post-stroke neurogenesis and angiogenesis

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Maloney Zacharie
Funded by
Amer Heart Assn

Scholarship & Fellowship

Collaborative Project
Active Project
Cardiovascular
Neuroscience
Basic Research

GABA and NPY Signaling Interact to Shape Inhibition in the Auditory Tectothalamic Pathway

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Silveira Marina
Funded by
NIH Natl Inst of Deafness/Communication

Applied Research

Collaborative Project
Active Project
Neuroscience
Basic Research

DNA methylation signatures of Alzheimer???s disease in aged astrocytes

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Carless Melanie
Funded by
NIH Natl Inst on Aging

Basic Research

Collaborative Project
Active Project
Aging
Neuroscience
Basic Research
Disease Modeling
Genetics

Development of small molecule inhibitors of RBM46 as novel male contraceptives

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Hermann Brian
Funded by
Natl Inst of Health

Applied Research

Collaborative Project
Active Project
Regenerative Medicine
Basic Research
Drug Discovery

SwRI DEVELOPS NOVEL SOLUTION TO ADVANCE SYNTHESIS FOR NERVE AGENT ANTIDOTES

Southwest Research Institute

Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.

Principal Investigator(s)
Dr. Shawn Blumberg
Funded by
Medical CBRN Defense Consortium

Southwest Research Institute has developed a unique technology (US20230242487A1) that enables the safe and efficient synthesis of organophosphorus nerve agent (OPNA) oxime antidotes. Using this technology, SwRI scientists can not only successfully synthesize currently known highly effective nerve agent countermeasures, but also effectively develop promising new drug candidates to treat nerve agent exposure.

Collaborative Project
Active Project
Infectious Disease
Other
Basic Research
Clinical Care
Disease Modeling
Drug Discovery